Novel pathway analysis of genomic polymorphism-cancer risk interaction in the Breast Cancer Prevention Trial

Purpose: Tamoxifen was approved for breast cancer risk reduction in high-risk women based on the National Surgical Adjuvant Breast and Bowel Project's Breast Cancer Prevention Trial (P-1:BCPT), which showed 50% fewer breast cancers with tamoxifen versus placebo, supporting tamoxifen's effi...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Dunn, Barbara K, Greene, Mark H, Kelley, Jenny M, Costantino, Joseph P, Clifford, Robert J, Hu, Ying, Tang, Gong, Kazerouni, Neely, Rosenberg, Philip S, Meerzaman, Daoud M, Buetow, Kenneth H
Format: Artigo
Jezik:Inglês
Izdano: e-Century Publishing Corporation 2010
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2998292/
https://ncbi.nlm.nih.gov/pubmed/21152245
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items